0.0035USD-59.77%Mkt Cap: —P/E: —Last update: 2026-06-01
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBa…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)26.55M USD
Gross Profit6.48M USD
Net Income (TTM)-91.72M USD
Revenue/Share1.037 USD
Last Price0.0035 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.87
EPS (Forward)—
52W Range
0.00350% of range0.0087
52W High0.0087 USD
52W Low0.0035 USD
Profitability
Gross Margin24.39%
Oper. Margin-492.15%
EBITDA Margin-203.44%
Profit Margin-345.45%
ROE240.96%
ROA-85.45%
Growth
Revenue Growth-77.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.25M USD
CapEx (TTM)—
FCF Margin20.28%
FCF Yield—
Net Debt68.54M USD
Net Debt/EBITDA-1.27
Balance Sheet
Debt/Equity-1.07
Current Ratio0.15
Quick Ratio0.14
Book Value/Sh-1.3200 USD
Cash/Share0.2130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float18.87M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)5.54K
Avg Vol (10d)—
Technical Indicators
RSI (14)51.9
MACD-0.0003
MACD Signal-0.0001
MACD Hist.-0.0001
BB Upper0.0102 USD
BB Middle0.0084 USD
BB Lower0.0066 USD
BB Width42.76%
ATR (14)0.0007 USD
Vol Ratio (20d)0.00x